A
Adient Medical
Development of absorbable medical devices with the premise that implants should be safe and effective during their useful lifetime
About Adient Medical
Adient Medical is a pioneering company specializing in the research, design, and development of absorbable medical devices aimed at preventing pulmonary embolism. Pulmonary embolism is a severe condition that ranks as the third largest killer in the nation, surpassing breast cancer, AIDS, and traffic fatalities combined. Adient collaborates with numerous industry partners, including the University of Texas MD Anderson Cancer Center, to create revolutionary medical devices. Their core product is a totally absorbable vascular filter made from industry-proven polymers, which offers exceptional strength and resorption properties. This innovative device is designed to be safe and effective during its useful lifetime and then simply vanish without the need for intervention, thereby eliminating the need for painful follow-up procedures and reducing the risk of future complications.
Adient Medical primarily serves healthcare providers and institutions that treat patients at risk of pulmonary embolism. Operating in the medical device market, the company employs a business model that focuses on the sale and distribution of its unique absorbable vascular filters. Revenue is generated through direct sales to hospitals and medical centers, as well as through partnerships and collaborations with other healthcare organizations.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Oct 2022 | $14M | $57M | Undisclosed | ↗ |
| SEED✓Equity / VC | Jan 2018 | — | — | JF2 Capital Partners | — |
Growth signals
Latest recorded traffic for Adient Medical is 720 monthly website visits, up 1100% over the last three months. Adient Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Adient Medical in the Pearland ecosystem
The Adient Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
TMCx Accelerator
Houston Angel Network
Texas Halo Fund
MedTech Innovator
JF2 Capital Partners
Series B and later1 investor entered at this stage
Broadview Ventures
Other known investors4 additional known investors
Grant Park Ventures
Idris Ayodeji Bello
LoftyInc Capital- TVTexas Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Adient Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Adient Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







